4 days Ago By ABMN Staff
Russell Investments Group Ltd. grew its holdings in Fortrea Holdings Inc. ( NASDAQ:FTRE – Free Report ) by 20.
8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 219,365 shares of the company’s stock after buying an additional 37,744 shares during the quarter. Russell Investments Group Ltd.
owned about 0.24% of Fortrea worth $4,091,000 at the end of the most recent quarter. A number of other institutional investors have also recently modified their holdings of the business.
Vanguard Group Inc. increased its holdings in Fortrea by 1.2% in the fourth quarter.
Vanguard Group Inc. now owns 9,884,256 shares of the company’s stock valued at $184,341,000 after buying an additional 120,599 shares in the last quarter. State Street Corp increased its stake in Fortrea by 7.
7% in the 3rd quarter. State Street Corp now owns 3,250,693 shares of the company’s stock valued at $65,014,000 after purchasing an additional 233,577 shares in the last quarter. Geode Capital Management LLC raised its holdings in Fortrea by 1.
4% during the third quarter. Geode Capital Management LLC now owns 1,502,546 shares of the company’s stock worth $30,059,000 after purchasing an additional 20,825 shares during the last quarter. Penn Davis Mcfarland Inc.
raised its holdings in Fortrea by 0.8% during the fourth quarter. Penn Davis Mcfarland Inc.
now owns 1,106,080 shares of the company’s stock worth $20,628,000 after purchasing an additional 8,884 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Fortrea by 3.
8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 612,897 shares of the company’s stock worth $11,431,000 after purchasing an additional 22,469 shares in the last quarter.
Fortrea Trading Down 9.3 % NASDAQ:FTRE opened at $4.86 on Wednesday.
Fortrea Holdings Inc. has a 12 month low of $4.83 and a 12 month high of $38.
04. The business’s 50-day moving average is $10.35 and its two-hundred day moving average is $16.
00. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.
18 and a quick ratio of 1.18. The firm has a market capitalization of $438.
37 million, a PE ratio of -1.42, a price-to-earnings-growth ratio of 1.78 and a beta of 2.
10. Wall Street Analysts Forecast Growth FTRE has been the subject of a number of research reports. Evercore ISI cut their target price on shares of Fortrea from $20.
00 to $15.00 and set an “in-line” rating for the company in a research report on Tuesday, March 4th. Barclays reaffirmed an “underweight” rating and issued a $6.
00 target price (down previously from $12.00) on shares of Fortrea in a research note on Thursday, April 10th. William Blair reissued a “market perform” rating on shares of Fortrea in a research report on Tuesday, March 4th.
The Goldman Sachs Group reduced their price objective on Fortrea from $22.00 to $11.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 4th.
Finally, Mizuho dropped their price objective on Fortrea from $12.00 to $10.00 and set a “neutral” rating for the company in a research report on Wednesday, April 9th.
Two investment analysts have rated the stock with a sell rating and ten have issued a hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $16.
70. Get Our Latest Stock Analysis on Fortrea Fortrea Profile ( Free Report ) Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services.
The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. Featured Stories Receive News & Ratings for Fortrea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortrea and related companies with MarketBeat.com's FREE daily email newsletter .
.
